Literature DB >> 19664865

Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I.

Ahmed M Sh El-Sharief1, Ziad Moussa.   

Abstract

Halogenated and alkylated N-arylcyanothioformanilides were reacted with the nucleophilic reagents triethylamine, hydrazine and diphenyldiazomethane to produce N-arylcyanothioformanilide ammonium salts, a thiosemicarbazide and a 2-(arylamino)-3,3-diphenylacrylonitrile, respectively. They also underwent several types of electrophilic reactions with aryl-, arylbisisocyanates and arylisothiocyanates to yield mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones. Treatment of imidazolidineiminothiones with hydrogen sulfide, substituted ortho-phenylenediamines and thiocarbohydrazide afforded the corresponding thiohydantoin, quinoxaline and imidazotriazine derivatives. Several of the synthesized products were subjected to in vitro biological evaluation against antitumor, antiviral, antimicrobial and antifungal strains. Most tested compounds showed significant activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664865     DOI: 10.1016/j.ejmech.2009.07.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  An environment-friendly methodology for the construction of diversified bicycloacenaphtho[1,2-d]imidazole-8-thione scaffolds using spinel NiFe2O4 nanoparticles as a sustainable catalyst.

Authors:  Soumitra Rana; Soumyadip Basu; Chhanda Mukhopadhyay
Journal:  Mol Divers       Date:  2022-01-03       Impact factor: 3.364

2.  MgO Nanoparticle-Catalyzed Synthesis and Broad-Spectrum Antibacterial Activity of Imidazolidine- and Tetrahydropyrimidine-2-Thione Derivatives.

Authors:  Hamid Beyzaei; Somaye Kooshki; Reza Aryan; Mohammad Mehdi Zahedi; Alireza Samzadeh-Kermani; Behzad Ghasemi; Mohammadreza Moghaddam-Manesh
Journal:  Appl Biochem Biotechnol       Date:  2017-07-05       Impact factor: 2.926

3.  New Imidazolidineiminothione, Imidazolidin-2-one and Imidazoquinoxaline 
Derivatives: Synthesis and Evaluation of Antibacterial and Antifungal Activities.

Authors:  Yousry A Ammar; Marwa A M Sh El-Sharief; Mostafa M Ghorab; Yehia A Mohamed; Ahmed Ragab; Samir Y Abbas
Journal:  Curr Org Synth       Date:  2016-06       Impact factor: 1.975

4.  Iodine-DMSO mediated conversion of N-arylcyanothioformamides to N-arylcyanoformamides and the unexpected formation of 2-cyanobenzothiazoles.

Authors:  Ziad Moussa; Zaher M A Judeh; Ahmed Alzamly; Saleh A Ahmed; Harbi Tomah Al-Masri; Bassam Al-Hindawi; Faisal Rasool; Sara Saada
Journal:  RSC Adv       Date:  2022-02-21       Impact factor: 3.361

Review 5.  A recent update on new synthetic chiral compounds with antileishmanial activity.

Authors:  Michele Verboni; Diego Olivieri; Simone Lucarini
Journal:  Chirality       Date:  2022-08-10       Impact factor: 2.183

6.  Highly bioactive novel aryl-, benzyl-, and piperazine-selenoureas: synthesis, structural characterization and in vitro biological evaluation.

Authors:  Ziad Moussa; Ranem Kaddoura; Haythem A Saadeh; Nael Abutaha; Saleh A Ahmed
Journal:  Heliyon       Date:  2022-09-21

7.  Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties.

Authors:  Heba A Elhady; Refat El-Sayed; Hamedah S Al-Nathali
Journal:  Chem Cent J       Date:  2018-05-09       Impact factor: 4.215

8.  Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.

Authors:  Mohamed F Zayed; Heba S Rateb; Sahar Ahmed; Osama A Khaled; Sabrin R M Ibrahim
Journal:  Molecules       Date:  2018-07-12       Impact factor: 4.411

9.  Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Authors:  Mohamed F Zayed; Sahar Ahmed; Saleh Ihmaid; Hany E A Ahmed; Heba S Rateb; Sabrin R M Ibrahim
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.